A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent

NCT00299026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: NIRx(TM) Paclitaxel-Coated Conformer Coronary Stent System

Sponsor

Boston Scientific Corporation